Funder
National Cancer Institute
Department of Defense
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring etofenamate hydrazide-hydrazone/copper(II) complexes: Synthesis, anticancer activity, carbonic anhydrase IX inhibition and docking studies;Journal of Molecular Structure;2024-09
2. Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future;Medicinal Research Reviews;2024-08-22
3. Recent Advancements in Refashioning of NSAIDs and their Derivatives as
Anticancer Candidates;Current Pharmaceutical Design;2024-05
4. New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment;Medicinal Chemistry Research;2023-08-18
5. In silico screening, synthesis, characterization and biological evaluation of novel anticancer agents as potential COX-2 inhibitors;DARU Journal of Pharmaceutical Sciences;2023-07-15